Skip to main content

Table 1 Patient demographics and tumor characteristics

From: DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker

 

Tumor (n = 27)

Non-Tumor (n = 3)

Age, mean (SD)

9.5 (5.5)

6 (5.6)

Range

1–18

0–11

Sex n (%)

  

Female

12 (44)

1 (33)

Male

15 (56)

2 (67)

Tumor type,a n (%)

  

Embryonal

6 (22)

 

Medulloblastoma

4

 

Embryonal (NOS)

2

 

Glioma

13 (48)

 

Anaplastic ganglioglioma

1

 

Desmoplastic ganglioglioma

2

 

Dysembryoplastic neuroepithelial tumor

2

 

Dysplastic gangliocytoma

1

 

Glioblastoma

1

 

Pilocytic astrocytoma

5

 

Low-grade glioma

1

 

Ependymoma

7 (30)

 

Subependymoma

1

 

Ependymoma

5

 

Myxopapillary ependymoma

1

 

WHO grade n (%)

  

I

12 (44)

 

II

5 (19)

 

III

2 (7)

 

IV

8 (30)

 

Sample location n (%)

  

Supratentorial

9 (33)

3 (100)

Subtentorial

17 (63)

 

Spinal

1 (4)

 

Median follow up (years)

14

 

Mean time to recurrence (years)

1.5

 
  1. aTumor type and grade were determined by a neuropathologist re-review of samples and distribution of tumor type was determined by prevalence at the institution